Board decision on the CRISPR gene editing technology
Written by Daniel van Herck :: [Thursday, 23 January 2020 14:59]
Created Thursday, 23 January 2020 Hits 896 views
An EPO board of appeal has dismissed the patent proprietor's appeal in case T 844/18, relating to the CRISPR gene editing technology, and thus confirmed the earlier revocation of the patent. No questions have been referred to the Enlarged Board.